Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years." ...

The U.S. Food and Drug Administration (FDA) announced Friday its rejection of MDMA as a treatment for PTSD. The decision was based on "significant limitations" that "prevent the agency from ...

The FDA rejected an application for the drug MDMA, in combination with therapy, as treatment for PTSD on Friday.

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.

The FDA rejected a company's application to market the party drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder.

The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD.

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years." ...

MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study FILE- A sign is displayed for the Food and Drug Administration offices in Silver Spring, Md., on Dec. 10, 2020.

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...